{"id":"NCT00131352","sponsor":"Genzyme, a Sanofi Company","briefTitle":"A Study of the Safety and Efficacy of Hylan G-F 20 (Synvisc) in Patients With Symptomatic Osteoarthritis of the Knee","officialTitle":"A Multi-Centre, Parallel, Double-Blind, Blinded Evaluator, Randomised, Placebo-Controlled Evaluation of the Efficacy and Safety of a Single Dose of 6 mL of Synvisc in Patients With Symptomatic Osteoarthritis of the Knee","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-05","primaryCompletion":"2006-09","completion":"2006-09","firstPosted":"2005-08-18","resultsPosted":"2012-01-19","lastUpdate":"2015-04-03"},"enrollment":253,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis, Knee","Musculoskeletal Diseases"],"interventions":[{"type":"DEVICE","name":"hylan G-F 20","otherNames":["Synvisc-One"]},{"type":"OTHER","name":"Phosphate Buffered Saline","otherNames":[]}],"arms":[{"label":"Synvisc","type":"EXPERIMENTAL"},{"label":"Saline Control","type":"PLACEBO_COMPARATOR"}],"summary":"This clinical study is to evaluate the safety and efficacy of hylan G-F 20 (Synvisc) in patients with symptomatic knee osteoarthritis (OA). Patients will be given 6 mL of hylan G-F 20 (Synvisc) (or a phosphate buffered saline control), with a possible repeat treatment with Synvisc after the week 26 visit.","primaryOutcome":{"measure":"Change From Baseline in Knee Pain Over the Course of the 26-week Initial Treatment Period As Measured by Participants Using the Western Ontario and McMaster Universities Osteoarthritis Index Likert Scale Version 3.1 (WOMAC LK 3.1) A (Pain) Subscale","timeFrame":"Day 0, up to week 26","effectByArm":[{"arm":"Synvisc","deltaMin":-0.84,"sd":0.06},{"arm":"Saline Control","deltaMin":-0.69,"sd":0.058}],"pValues":[{"comp":"OG000 vs OG001","p":"0.047"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":21,"countries":["Belgium","Czechia","France","Germany","Netherlands","United Kingdom"]},"refs":{"pmids":["19304567"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":123},"commonTop":["Arthralgia","Joint stiffness","Headache","Back pain","Joint effusion"]}}